英矽智能发布ISM001-055的吸入制剂临床前候选药物 (IMAGE)

InSilico Medicine

英矽智能发布ISM001-055的吸入制剂临床前候选药物

Caption

吸入给药直接靶向病灶，具有技术壁垒高、起效剂量小、安全窗口大、毒副作用小等潜在优势

Credit

英矽智能

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.